DLG5 and inflammatory bowel disease: In summary, despite the limitations above, our results suggest that the DLG5 R30Q polymorphism is associated with a reduced risk of IBD in Europeans, while P1371Q is associated with an increased risk in Europeans and Americans, but could serve as a protective factor in Asian population.